Trial Profile
Effects of sequentially adding dulaglutide to therapy in people with type 2 diabetes mellitus who had previously been receiving empagliflozin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jul 2018
Price :
$35
*
At a glance
- Drugs Dulaglutide (Primary) ; Empagliflozin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 28 Jul 2018 New trial record
- 11 Jun 2018 Results presented at the 28th European Meeting on Hypertension and Cardiovascular Protection